Lung Nodules: Is a Bronchoscopy Always Necessary?
"New research sheds light on when a preoperative bronchoscopy might not be beneficial for persistent ground-glass nodules."
The detection of pulmonary nodules, small spots on the lungs, is a common and often worrying clinical issue. As a result of more frequent and advanced imaging techniques, particularly low-dose chest computed tomography (CT) scans, more of these nodules are being discovered. While many are benign, some can indicate early-stage lung cancer, making their evaluation crucial.
Persistent ground-glass nodules (GGNs) are a specific type of pulmonary nodule characterized by their hazy appearance on CT scans. These nodules can represent various conditions, including focal fibrosis (scarring), premalignant lesions, or subtypes of adenocarcinoma, a common type of lung cancer. Unlike solid nodules, GGNs can be challenging to diagnose without invasive procedures, often requiring long-term monitoring to determine their nature.
Traditionally, before surgical removal of lung nodules, a procedure called flexible bronchoscopy (FB) is performed to examine the airways and collect tissue samples. However, the utility of FB in the preoperative assessment of GGNs has been a topic of debate. This article examines the findings of a recent study investigating whether routine preoperative FB is always necessary for patients with persistent GGNs, potentially reducing the need for invasive procedures in select cases.
Bronchoscopy and Ground-Glass Nodules: What the Research Shows

A recent study published in PLOS One investigated the diagnostic value of preoperative flexible bronchoscopy (FB) in patients with persistent ground-glass nodules (GGNs) who were suspected of having lung cancer. The researchers retrospectively analyzed data from 264 patients with 296 GGNs who underwent both preoperative FB and surgical resection.
- Limited Diagnostic Value: Preoperative FB identified malignancy in only 3 of 208 GGNs (1%) examined via bronchial washing cytology, and all three were part-solid GGNs. No other etiology was identified through FB.
- No Change in Surgical Strategy: Routine preoperative FB did not change the planned surgical approach for any patient in the study.
- High Malignancy Rate: Surgical resection subsequently confirmed that 271 of the GGNs (91%) were malignant. The resected malignancies included invasive adenocarcinoma(58%), minimally invasive adenocarcinoma (10%) and adenocarcinoma in situ (23%).
- Benign Cases: The remaining 25 GGNs (9%) were confirmed as benign at surgical resection.
The Future of GGN Management
The study's findings indicate that routine preoperative FB may not be necessary for all patients with persistent GGNs, particularly those with small, pure GGNs. The decision to perform FB should be individualized based on the nodule's characteristics, patient risk factors, and clinical context.
Shared decision-making between physicians and patients is crucial in determining the best course of action. Patients should be informed about the potential benefits and risks of FB, as well as alternative diagnostic and management strategies, such as CT surveillance.
Further research is needed to refine the criteria for selecting patients who may benefit from preoperative FB. Prospective studies using advanced bronchoscopic techniques, such as navigational bronchoscopy, could help improve the diagnostic yield and guide treatment decisions.